Davies GC, Sobel M., Salzman EWElevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass. Circulation1980; 61: 808-14.
4.
Levin E.Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci USA1983; 80: 6804-6807.
5.
Collen D.On the regulation and control of fibrinolysis. Thromb Haemostas1980; 43: 77-89.
6.
Stibbe J., Kluft C., Brommer EJ, Gomes M., de Jong DS, Nauta J.Enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator . Eur J Clin Invest1984; 14: 375-82.
7.
Cwikel BJ, Barouski-Miller PA, Coleman PL, Gelehrter TDDexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells. J Biol Chem1984; 259: 6847-51.
8.
van Oeveren W. , Eysman L., Roozendaal KJ, Brommer Ejp, Gu YY, Wildevuur Crh.Prednisolone inhibits fibrinolysis and biomaterial-independent complement activation during cardiopulmonary bypass. (In prepartion).
9.
Niewiarowski S., Budzynski AZ, Morinelli TA, Brudzynski TM, Stewart GJExposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem1981; 256: 917-25.
Winocour PD , Kinlough-Rathbone RL, Richardson M., Mustard RFReversal of shortened platelet survival in rats by the antifibrinolytic agent, epsilon aminocaptroic acid. J Clin Invest1983; 71: 159-64.
12.
van Oeveren W., Jansen Njg, Bidstrup BP et al. Effects of aprotinin on hemostatic mechanisms in cardiopulmonary bypass. Ann Thorac Surg (in press).
13.
Kirklin JK, Westaby S., Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico ADComplement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg1983; 86: 845-57.
14.
Chenoweth DE , Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JWComplement activation during cardiopulmonary bypass. N Engl J Med1981; 304: 497-503.
15.
Kirklin JK, Chenoweth DE, Naftel DC et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg1986; 41: 193-99.
van Oeveren W., Kazatchkine MD, Descamps-Latscha B. et al. Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation . J Thorac Cardiovasc Surg1985 ; 89: 888-99.
18.
Faymonville ME, Deby-Dupont G., Larbuisson R. et al. Prostaglandin E2, prostacyclin, and thromboxane changes during nonpulsatile cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg1986; 91: 858-66.
19.
Neuhof H.Acute respiratory distress syndrome: the pathogenetic role of the 'classical' cascade systems and the arachidonic acid metabolism. Intensive Care News1983; 2: 5-9.
20.
Goetzl EJ, Brindley LL, Goldman DWEnhancement of human neutrophil adherence by synthetic leukotriene constituents of the slow-reacting substance of anaphylaxis. Immunol1983; 50: 35-41.
21.
Cochrane CG , Spragg RG, Revak SDStudies on the pathogenesis of the adult respiratory distress syndrome: evidence of oxidants in the broncheoalveolar lavage fluid . J Clin Invest1983; 71: 754-61.
22.
Royston D., Fleming JS, Desai JB, Westaby S., Taylor KMIncreased production of peroxidation products associated with cardiac operations . J Thorac Cardiovasc Surg1986 ; 91: 759-66.
23.
Gerard C., Chenoweth DE, Hugli TEResponse of neutrophils to C5a: a role for the oligosaccharide moiety of human C5a desarg-74 but not of C5a in biologic activity. J Immunol1981; 127: 1978—82.
24.
Melamed J., Medicus RG, Arnaout MA, Colten HRInduction of granulocyte histaminase release by particle-bond complement C3 cleavage products (C3b, C3bi) and IgG. J Immunol1983; 131: 439-44.
25.
Blakemore WS , McGarrity GJ, Thurer RJ, Wallace HW, MacVaugh H. III, Coriell LLInfection by air-borne bacteria with cardiopulmonary bypass. Surgery1980; 70: 830-38.
26.
van Oeveren W., Dankert J., Boonstra PW, Elstrodt JM, Wildevuur Crh.Airborne contamination during cardiopulmonary bypass: the role of cardiotomy suction . Ann Thorac Surg1986; 41: 401-406.
27.
Lee WH, Hairston P.Structural effects on blood gas interface. Fed Proc1971; 30: 1615.
28.
van Oeveren W., Dankert J., Wildevuur W., Wildevuur Chr.Prophylactic antibiotic treatment prevents infection after cardiopulmonary bypass: a study in dogs. Ann Thorac Surg (in press).
29.
van Oeveren W., Dankert J., Wildevuur Crh.Bubble oxygenation and cardiotomy suction impair the host defence during cardiopulmonary bypass. A study in dogs. Ann Thorac Surg (in press).